スポンサーリンク
Department of Pharmaceutics | 論文
- 塩酸サルポグレラートによる血小板凝集抑制作用の速度論的解析とその処方設計への応用 : 未変化体及び活性代謝物(M-1)の血小板膜上5-HT_2受容体への可逆的阻害を考慮したPK/PDモデルの構築
- 特定薬剤治療管理料算定処理機能を搭載した TDM 実施情報伝達システムの開発
- CYP2C9遺伝的多型がLosartanの体内動態および血圧降下作用に及ぼす影響
- Total body propofol clearance (TBPC) after living-donor liver transplantation (LDLT) surgery is decreased in patients with a long warm ischemic time
- Pharmacobezoar complicating treatment with sodium alginate
- シラスタチンによるバンコマイシン腎障害軽減作用の生理学的解析
- Inhibitory Effects of Nicardipine to Cytochrome P450 (CYP) in Human Liver Microsomes(Biopharmacy)
- テルグリドの高プロラクチン血症治療効果のドパミンD_2受容体結合占有を考慮したPK/PD解析
- プロポフォール薬物動態と心拍出量
- Thiopurine Methyltransferase Genotype and Phenotype Status in Japanese Patients with Systemic Lupus Erythematosus(Biopharmacy)
- Genotyping of Thiopurine Methyltransferase Using Pyrosequencing^(Biopharmacy)
- P-35 腸溶性アスピリン製剤による抗血小板作用の速度論的解析
- シロスタゾールによる血小板凝集抑制作用の速度論的解析とその処方設計への応用 : 血小板中ホスホジエステラーゼの可逆的阻害を考慮した PK/PD モデルの構築
- Simultaneous Assessment of the In Vivo Amount of CYP1A2 and CYP3A2 by the PKCYP-test Using Theophylline in Rats
- Application of the PKCYP-test to Predict the Amount of in Vivo CYP2C11 Using Tolbutamide as a Probe
- Determination of Isepamicin in Human Plasma by HPLC with Fluorescence Detection after Derivatization Using 6-Aminoquinolyl-N-hydroxysuccinimidyl-carbamate(Analytical Biochemistry)
- A novel intronic mutation that may affect genotyping result of CYP2C8 by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) is strongly associated with CYP2C8^*3 in a South American population
- Time-Dependent Induction of Midazolam-1-hydroxylation Enzymes in Rats Treated with St. John's Wort(Biopharmacy)
- Successful Treatment of Severe Hyperammonemia Using Sodium Phenylacetate Powder Prepared in Hospital Pharmacy
- Quantitative determination of domperidone in rat plasma by high-performance liquid chromatography with fluorescence detection